AETHLON MEDICAL INC Cash Flow Statement
AEMD|12 years of annual SEC 10-K data (FY2011-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 12 fiscal years. All figures from audited SEC 10-K filings.
AETHLON MEDICAL INC used $8M in operating cash flow and negative free cash flow of $8M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$13.4M | -$12.2M | -$12.0M | -$6.4M | -$6.2M | -$6.2M | -$4.9M | -$7.3M | -$13.4M | -$4.9M | -$8.1M | -$8.1M |
| Depreciation & Amortization | $339.6K | $359.1K | $240.9K | $26.4K | $30.7K | $30.7K | $38.5K | $32.4K | $21.1K | $10.5K | $17.2K | $17.2K |
| Operating Cash Flow | -$7.6M | -$10.1M | -$10.5M | -$5.2M | -$4.3M | -$4.3M | -$4.3M | -$3.5M | -$2.1M | -$2.1M | -$1.8M | -$1.8M |
| Capital Expenditures | $0 | $250.9K | $943.1K | $151.7K | $0 | $0 | $9.3K | $16.4K | $96.1K | $0 | $1.7K | $1.7K |
| Free Cash Flow | -$7.6M | -$10.4M | -$11.4M | -$5.3M | -$4.3M | -$4.3M | -$4.3M | -$3.5M | -$2.2M | -$2.1M | -$1.8M | -$1.8M |
| Share Buybacks | - | - | - | - | - | $193.9K | $0 | $378.5K | - | - | - | - |
| FCF Margin | - | - | -1993.6% | -822.7% | -1869.8% | -1869.8% | -489.4% | -898.4% | -137.6% | -170.6% | -135.6% | -135.6% |